Altrius Capital Management Inc Astrazeneca PLC Transaction History
Altrius Capital Management Inc
- $414 Million
- Q2 2025
A detailed history of Altrius Capital Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Altrius Capital Management Inc holds 118,022 shares of AZN stock, worth $8.74 Million. This represents 1.99% of its overall portfolio holdings.
Number of Shares
118,022
Previous 117,654
0.31%
Holding current value
$8.74 Million
Previous $8.65 Million
4.63%
% of portfolio
1.99%
Previous 2.16%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,422Shares Held
509MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.23 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.05 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.64 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.36 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.32 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...